Under what’s been dubbed “drug transparency,” pharmaceutical companies would have to itemize the various costs that go into their product. The idea has made an appearance in President Barack Obama’s 2017 budget and been proposed in states including Massachusetts, Vermont, New York and California.
Read Full Article »
